baber/WOPTO huggingface dataset:
Patent AU-2001217945-B2 (AU)
Title: Orthopedic ankle brace
Inventor: WATTS ERIC
IPC: A61F5/00
Filed: 2000-11-22
Granted: 2006-04-13
Abstract: A unitary boot-type ankle brace is provided having the capability of stabilizing an ankle against inversion and eversion without limiting normal plantarflexion and dorsiflexion of the ankle and while simultaneously providing focal compression of the anterior talofibular ligament. The brace is preferably constructed of a flexible material and includes a medial side portion dimensioned and configured to extend along a medial side of a user's leg and foot, and having a lateral side portion dimensioned and configured to extend along a lateral side of the leg and foot. The side portions are joined to a forwardly extending forefoot sleeve portion and to a base portion. In a primary aspect of the invention the side portions define a rear opening for insertion of the foot with a strap for selectively connecting the side portions adjacent the user's heel.
Patent AU-2001241757-B2 (AU)
Title: Method of converting hall-heroult cells to inert anode
Inventor: MOORE ROBERT C
IPC: C25C3/06
Filed: 2001-02-23
Granted: 2004-11-18
Abstract: A method is provided for retrofitting conventional aluminum smelting cells with inert anode assemblies which replace the consumable carbon anodes of the cell. The inert anode assemblies are pre-heated prior to introduction into the operating cell. Insulation may be installed for reducing heat loss during operation of the retrofit cells.
Patent AU-2001247691-B2 (AU)
Title: Improved easy-open end and method of making
Inventor: ZYSSET EDGAR
IPC: B21D51/38
Filed: 2001-03-23
Granted: 2004-10-14
Abstract: A method of making an easy-open end for a container includes steps of forming first and second grooves in a panel of a can end blank, the grooves extending below the level of the panel to form inner and outer beads and forming a central bead in the panel between the first and second grooves so that the central bead extends above the panel. A score is then formed along the central bead by simultaneously forming the score and compressing the central bead, so that the depth of the score and the thickness of the central bead are both positively controlled. The inner and outer beads are then forced toward each other and then toward the panel, and the central bead is forced toward the panel. A pull-tab is then fixed to the end. This process permits the score residual to be controlled to a greater tolerance than the conventional processes, and is also more material efficient.
Patent AU-2001255543-B2 (AU)
Title: Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same
Inventor: BARRY EILEEN M
IPC: C12N/
Filed: 2001-04-20
Granted: 2005-06-23
Abstract: Compositions comprising products of the csa operon, an isolated nucleic acid encoding the csa operon or functional fragments thereof, purified polypeptide products of the csa operon or functional fragments thereof, methods of eliciting an immune response to these products, and methods of producing products of the csa operon are disclosed herein.
Patent AU-2001263835-B2 (AU)
Title: Haemostatically active preparation containing vwf and method for the production thereof
Inventor: GRUBER GERHARD
IPC: A61K35/16
Filed: 2001-04-04
Granted: 2005-06-09
Abstract: Preparation of a composition comprising hemostatically active von Willebrand factor (vWF) comprises (i) chromatographic purification of a vWF-containing plasma fraction; (ii) purifying the collected active fraction by gel permeation to produce a heat-stable fraction and (iii) heating this to inactivate viruses. Preparation of a composition comprising hemostatically active von Willebrand factor (vWF) comprises: (i) chromatographic purification of a vWF-containing plasma fraction on an ion-exchange material (A); (ii) purifying the collected active fraction by gel permeation to produce a heat-stable fraction and (iii) heating this to inactivate viruses. (A) comprises anion-exchange groups on a grafted polymeric structure (a tentacle material). An Independent claim is also included for a hemostatically active vWF-containing composition made this way.
Patent AU-2002227830-B2 (AU)
Title: Quick-install irradiation unit and method of making same
Inventor: WISER FORWOOD CLOUD III
IPC: A61L2/10
Filed: 2002-01-25
Granted: 2007-03-22
Abstract: A quick-install irradiation unit for irradiating a surface includes an adapter that accepts a frame for supporting an ultraviolet lamp with a reflector or a lens for focusing the radiation on the surface. The unit may include a housing secured to one end of the frame containing a drive motor and a cam assembly which oscillate the reflector, if the radiation is focused on a predefined area of the surface at any given time. The unit can be quickly installed in any orientation on practically any flat surface.
Patent AU-2002328546-B2 (AU)
Title: Laminated zeolite composite and method for production thereof
Inventor: TOMITA TOSHIHIRO
IPC: B01D69/10
Filed: 2002-09-12
Granted: 2007-06-07
Abstract: The laminated zeolite composite of the present invention is characterized in that it comprises a MFI membrane being constituted by a MFI type zeolite and having a SiO2/Al2O3 (molar ratio) of 40 to 100, and a porous substrate being constituted by a MFI type zeolite and having a SiO2/Al2O3 (molar ratio) of 20 to 400, and that the MFI membrane is formed on the porous substrate. The composite has high separation characteristic and high permeability. <IMAGE>
Patent AU-2003211145-B2 (AU)
Title: Modified release formulations of at least one form of tramadol
Inventor: SETH PAWAN
IPC: A61K47/02
Filed: 2003-02-21
Granted: 2007-07-12
Abstract: The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functional groups.
Patent AU-2003260365-B2 (AU)
Title: Denatured carob flour (DCF) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it
Inventor: MORA BALTAZAR RUIZ-ROZO CALVO
IPC: A23L5/20
Filed: 2003-08-05
Granted: 2008-05-15
Abstract: The present invention provides an improved denatured carob flour, which includes 2 to 15% sugars, 0.2 to 1.5% cyclitols (pinitol), 2 to 10% lignins, 10 to 30% celluloses, 3 to 20% hemicelluloses, 1 to 6% pectins, 25 to 55% condensed tannins, 3 to 9% protein and less than 8% water. The invention further provides a process to obtain a denatured carob flour that includes the following steps: a. cleaning the whole fruit; b. crushing the carob fruits; c. separating the carob seeds and kibbled carob pulp, d. toasting between 130 to 200° C.; e. an extracting process; f. separating; g. milling 90% of particles below 250 pm; h. separating; i. drying below 8%; and j. classifying (sieving).
Patent AU-2003272716-B2 (AU)
Title: Liquid uncrosslinked michael addition oligomers prepared in the presence of a catalyst having both an epoxy moiety and a quaternary salt
Inventor: GOULD MICHAEL L
IPC: C08F222/10
Filed: 2003-09-26
Granted: 2008-02-14
Abstract: The uncrosslinked liquid oligomeric compositions of this invention are made by the Michael addition reaction of acetoacetate-functional donor compounds with multifunctional acrylate acceptor compounds where the equivalent ratios of multifunctional acrylate to acetoacetate vary from >=1:1 to >=13.2:1 depending on the functionality of both multifunctional acrylate and acetoacetate in the presence of a catalyst comprising an epoxy moiety and a quaternary salt. Unusable gelled or cured oligomer products occur below the claimed ranges. The liquid oligomers of this invention are further crosslinked to make coatings, laminates and adhesives.
Patent AU-2004200960-B2 (AU)
Title: Hydrocephalus shunt system with endoscopic placement features
Inventor: KRAUS ROBERT G
IPC: A61M27/00
Filed: 2004-03-04
Granted: 2010-06-10
Abstract: A shunt system for controlling the flow of fluid from one region of a patient to a different region of the patient's body. The shunt system includes endoscopic placement features so that the system can be placed endoscopically in a minimally invasive surgery. Also provided is a single fluid flow control device having flow control characteristics previously obtainable only by connecting in series two or more shunt system components. In addition, the shunt system includes a selectively engageable locking mechanism that allows the system to be assembled quickly and easily, without the need for sutures or adhesives. The present assembly process minimizes the possibility of any unintended fluid leakage from the device. <IMAGE>
Patent AU-2004235618-B2 (AU)
Title: Cholesterol recognition sequence
Inventor: HUA LI
IPC: A61P3/06
Filed: 2004-12-02
Granted: 2007-10-11
Abstract: Peptides containing a cholesterol interaction/recognition consensus sequence is described and methods of use thereof.
Patent AU-2004240219-B2 (AU)
Title: Sulfur-containing proanthocyanidin oligomer composition and process for producing the same
Inventor: YUAN LAN
IPC: C07D311/62
Filed: 2004-05-25
Granted: 2010-05-27
Abstract: Provided are: method of producing a sulfur-containing proanthocyanidin oligomer by reducing the molecular weight of proanthocyanidin in plants so that they can be readily absorbed through the intestine of an organism; and a health food composition and a pharmaceutical composition which contain the resultant sulfur-containing proanthocyanidin oligomer as an active ingredient and which are useful for treating and preventing various lifestyle-related diseases and brain diseases caused by generation of active oxygen species as well as for preventing aging.
Patent AU-2004255905-B2 (AU)
Title: Preparation of 1,3-diphenylprop-2-en-1-one derivatives
Inventor: DELHOMEL JEAN-FRANCOIS
IPC: C07C323/52
Filed: 2004-07-08
Granted: 2010-11-18
Abstract: The invention relates to a method for the preparation of de 1,3-diphenylprop-2-en-1-one substituted on one of the two phenyl groups by a carboxyalkyloxy group or a carboxyalkylthio group.
Patent AU-2005237123-B2 (AU)
Title: Ambulatory calf compressor device
Inventor: RAMAKRISHNA RAJ
IPC: A61N1/36
Filed: 2005-11-24
Granted: 2012-07-05
Abstract: An Ambulatory Calf Compressor Device is disclosed. The device consists of an elastic silicone rubber sheet 1 with two brass bars 2 embedded in it. The alloy bars 2 have BioMetal filaments strung between them 3 and two electrical wires 5,6. The electrical wires are subsequently attached to a rechargeable Li-Polymer 3.7v battery 7. The brass bars are attached to the BioMetal filaments via eyelets 4. An electrical switch 8 which can break the electrical circuit of the wires 5,6 can be employed to activate or turn off the device. A pre set or programmable circuit board regulates the contractive phases of the device'9.The inner workings of the device listed above may be encased in a comfortable nylon coating (not shown) and secured using a Velcro strap or other method of securing (not shown) Raj RAMAKRISHNA 7/11/2004 I: * a * N 1) a ft a (I a a a 0~- a a It ~0- *---- 0 I a t ft 7
Patent AU-2005245403-B2 (AU)
Title: Carboxamido opioid compounds
Inventor: PHILIP PITIS M
IPC: A61K31/165
Filed: 2005-05-11
Granted: 2012-04-19
Abstract: This invention is directed to carboxamido opioid compounds pharmaceutically useful as agents for treating or modulating a central nervous system disorder and methods for treating or modulating a central nervous system disorder.
Patent AU-2005304936-B2 (AU)
Title: Conveyor belt construction for a platen-type conveyor
Inventor: BUCHKO RAYMOND G
IPC: B65G23/44
Filed: 2005-11-03
Granted: 2011-02-10
Abstract: A conveyor belt construction includes a flexible conveyor belt defining inner and outer surfaces, and a series of clamp assemblies that are used to mount conveying members to the conveyor belt. One of the clamp members defines a convex engaging area that engages one of the surfaces of the conveyor belt, and the other of the clamp members defines a concave engaging area that engages the other surface of the conveyor belt. The clamp members are secured together and the belt is sandwiched between the concave and convex areas of the clamp members. The conveyor belt construction is engaged about a pair of rotatable members. The concave and convex areas of the clamp members take up a length of the conveyor belt, to tighten the conveyor belt onto the rotatable members without the use of a belt tensioner. The conveying members may be in the form of platens mounted to the outer clamp members.
Patent AU-2005311709-B2 (AU)
Title: Compositions and methods for treating neoplastic diseases
Inventor: CHAUHAN DHARMINDER
IPC: A61P35/00
Filed: 2005-12-02
Granted: 2011-07-28
Abstract: Disclosed herein are compositions and methods for treating neoplastic diseases. Included are compositions and methods that are effective against multiple myeloma cells resistant to conventional and bortezomib treatment. Furthermore, combination treatment with two different proteosome inhibitors is shown to be synergistic for treating multiple myeloma.
Patent AU-2006207887-B2 (AU)
Title: Waste water treatment process
Inventor: CLOSE MALCOLM
IPC: C12N1/20
Filed: 2006-09-07
Granted: 2012-06-14
Abstract: A process for treating waste water, the process comprising the steps of: (a) collecting the waste water; 5 (b) adding a nutrient dose to the collected waste water; and (c) subjecting the dosed waste water to aerobic digestion. H:\SherylM\Keep\Speci\P62069.doC 7/09/06
Patent AU-2006301935-B2 (AU)
Title: Method and device for forming micro structured fibre
Inventor: MONRO TANYA
IPC: B29C48/05
Filed: 2006-10-12
Granted: 2012-11-29
Abstract: A die and method for extruding an extrudable material to form an extruded member is described. In one embodiment, the die comprises a barrier member comprising a plurality of feed channels that extend through the barrier member. Furthermore, the die incorporates a passage forming member extending from the barrier member substantially in the direction of extrusion. The feed channels are arranged with respect to the passage forming member to allow the extrudable material to substantially flow about the passage forming member to form a corresponding passage in the extruded member.
Patent AU-2006326980-B2 (AU)
Title: Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
Inventor: SCHLARB KERSTIN
IPC: C07D235/14
Filed: 2006-12-20
Granted: 2012-07-05
Abstract: The invention relates to a process for preparing a salt of an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine, characterised in that (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, b) i) the product thus obtained is hydrogenated, ii) optionally the amidino group is carbonylated, without isolating the intermediate product of the hydrogenation beforehand and iii) without prior isolation of the intermediate product of the carbonylation the desired salt is isolated.
Patent AU-2007201193-B2 (AU)
Title: Molded articles and molding methods particularly for a protective helmet
Inventor: PIERCE BRENDAN
IPC: A42B3/06
Filed: 2007-03-20
Granted: 2009-09-10
Abstract: Protective structures, such as helmets, and methods for molding the same. In certain respects, one or more tunnels are formed in or integral to an outer shell for a helmet to provide ventilation, for example. In other respects, an impact liner materials, such as EPS, may be directly in-molded to shells suitable for use in motorcycle helmets and other helmets that must meet certain standards. The impact liner may include one or more venting channels that are coupled to a tunnel integral to the shell structure.
Patent AU-2007201562-B2 (AU)
Title: Medical instrument having an articulatable end effector
Inventor: LU IFUNG
IPC: A61B10/04
Filed: 2007-04-10
Granted: 2012-07-12
Abstract: A medical instrument includes a flexible tube, a distal member, a flexible end effector activation wire, a proximal member, and a flexible first cable. The distal member is connected to the distal tube portion. The activation wire is positioned within the tube. The proximal member is attached to the tube. The first cable is positioned outside the tube, is substantially transversely constrained by the proximal member, and has a first distal cable portion attached to the distal member. Lengthwise translation of the first cable articulates the distal member with respect to the proximal member. Another instrument includes a drive screw which articulates an end effector (e.g., a grasper) pivotally connected to a tube. An additional instrument includes a drive screw which articulates a distal medical instrument member pivotally connected to a tube. A medical end effector (e.g., a snare) is positionable in a lumen of the distal medical instrument member. co
Patent AU-2007224396-B2 (AU)
Title: Direct conversion receiver architecture
Inventor: KANG INJUP
IPC: H04L27/22
Filed: 2007-10-15
Granted: 2010-07-08
Abstract: An apparatus and method in a wireless communication system, the apparatus comprising: first means for amplifying a received signal; means for cancelling a DC offset in the amplified signal; second means for digitally amplifying the DC offset cancelled signal; and means for measuring the digitally amplified signal and to control the gains of the first and second amplifying means.
Patent AU-2007272248-B2 (AU)
Title: Apparatus and methods for real-time verification of radiation therapy
Inventor: ISLAM MOHAMMAD K
IPC: G01T1/15
Filed: 2007-07-10
Granted: 2013-05-16
Abstract: Various embodiments are described herein for an area integrated fluence monitoring sensor that can be used to measure a radiation dose. The sensor comprises at least one Gradient Ion Chamber (GIC) comprising an ion chamber having a volume gradient across a length or width thereof, a gas or liquid located within the ion chamber and an electrode to detect ions generated within the gas or liquid when the at least one GIC is subjected to an ionizing radiation beam. Various embodiments are also described herein for an Integral Quality Monitoring system and associated method that can be used to measure and monitor the quality of radiation doses provided by a radiation treatment system.
Patent AU-2007282556-B2 (AU)
Title: Aminoalcohol derivative and immunosuppressant containing the same as active ingredient
Inventor: FUJII KIYOSHI
IPC: A61P17/06
Filed: 2007-08-07
Granted: 2012-03-08
Abstract: Disclosed is an aminoalcohol derivative which is useful as an excellent immunosuppressant. Specifically disclosed is an aminoalcohol derivative represented by the general formula (1) below, which is a highly safe compound having excellent immune suppressing activity.
Patent AU-2007285057-B2 (AU)
Title: Mesenchymal stem cell conditioned medium
Inventor: LIM SAI KIANG
IPC: A61K35/28
Filed: 2007-08-15
Granted: 2013-08-01
Abstract: We disclose a method of preparing a conditioned cell culture medium, the method comprising the steps of: (a) culturing a mesenchymal stem cell (MSC), a descendent thereof or a cell line derived therefrom in a cell culture medium; and (b) optionally isolating the cell culture medium; in which the mesenchymal stem cell (MSC) is obtained by propagating a cell obtained by dispersing a embryonic stem (ES) cell colony, or a descendent thereof, in the absence of co-culture in a serum free medium comprising FGF2.
Patent AU-2007300392-B2 (AU)
Title: Enhanced oxygenate conversion and product cracking integration
Inventor: MILLER LAWRENCE W
IPC: C07C1/00
Filed: 2007-01-26
Granted: 2011-09-08
Abstract: Water and/or oxygenate content in olefin cracking feeds is/are reduced or minimized to enhance light olefin production via integrated oxygenate conversion and product olefin cracking.
Patent AU-2007327048-B2 (AU)
Title: Amino quinazolines derivatives with blood platelet reducing properties
Inventor: BERNARD GOLDING
IPC: A61P7/02
Filed: 2007-11-19
Granted: 2012-01-12
Abstract: This invention relates to the discovery of prodrugs of 3-or 5-substituted analogues of the selective platelet lowering agent anagrelide which have reduced potential for cardiovascular side-effects and which should therefore lead to improved patient compliance and safety in the treatment of myeloproliferative diseases. More specifically, the present invention relates to prodrugs of certain imidazoquinazoline derivatives which have utility as platelet lowering agents in humans. The compounds of the present invention function by inhibiting the formation of blood platelet.
Patent AU-2007337213-B2 (AU)
Title: Tannin based polymeric coagulants composition and method of use
Inventor: KAWAWA BARAKA
IPC: C02F101/32
Filed: 2007-12-10
Granted: 2012-06-28
Abstract: Composition and method of use for tannin based environmentally benign polymeric coagulants are disclosed. Tannin based coagulants are copolymers of naturally occurring tannins and a cationic monomer. One embodiment of the present invention provides for a composition of a tannin based polymeric coagulant which is comprised of N,N-(dimethylaminoethyl) methacrylate (MADAME) polymerized using t- butylhydroperoxide and sodium metabisulfite. The resulting poly M AD AME is converted to hydrochloride and then blended /reacted in an aqueous medium with tannin to obtain a homogenous poly(MADAME)-Tannin composition. The method of use comprises adding an amount of the composition effective for the purpose of clarifying oily wastewater from food and beverage, steel, automotive, transportation, refinery, pharmaceutical, metals, paper and pulp, chemical processing and hydrocarbon processing industries.
Patent AU-2007339307-B2 (AU)
Title: Process for preparing 2-amino-5-cyanobenzoic acid derivatives
Inventor: ANNIS GARY DAVID
IPC: C07C255/58
Filed: 2007-12-18
Granted: 2012-06-14
Abstract: Disclosed is a method for preparing a compound of Formula (1) comprising contacting a compound of Formula (2) with a metal cyanide reagent, a copper (I) salt reagent, an iodide salt reagent and at least one compound of Formula (3): wherein R is NHR or OR; R is CH or Cl; R is H, C-C alkyl, cyclopropyl, cyclopropylcyclopropyl, cyclopropylmethyl or methylcyclopropyl; R is H or C-C alkyl; Y is Br or Cl; X is NR or O; n is 0 or 1; and R, R, R, R, R, R, R, R and R are as defined in the disclosure. Also disclosed is a method for preparing a compound of Formula (2) wherein Y is Br and R is NHR comprising introducing a gas containing bromine into a liquid containing a compound of Formula (4), and further disclosed is a method for preparing a compound of Formula (5) wherein R, R, R and Z are as defined in the disclosure using a compound of Formula (1) characterized by preparing the compound of Formula (1) by the method disclosed above.